Skip to main content
. 2024 Apr 3;25(7):3976. doi: 10.3390/ijms25073976

Figure 4.

Figure 4

B7-H3 staining in breast tumours in the QBBM cohort. (a) Representative immunohistochemistry images of matched breast tumour and brain metastasis for B7-H3 staining. (b) Chi-square analysis of the proportion of matched breast cancer and BrM cases with positive and negative B7-H3 expression. (c) Chi-square analysis of proportions of matched breast cancer and BrM cases stratified by B7-H3 staining compared across BC subtypes (ER+, HER2+, and TNBC). (dk) KM analysis of B7-H3 expression and BCSS cases compared across all tumours (d), ER+ (f), HER2+ (h), and TNBC (j). KM analysis of B7-H3 expression and BrMSS cases compared across all tumours (e), ER+ (g), HER2+ (i), and TNBC (k). Note the X axis changes between breast cancer and BrM. BC, breast cancer; BrM, brain metastasis; HER2+, human epidermal growth factor receptor 2; ER+, oestrogen receptor; KM, Kaplan–Meier; TNBC, triple negative breast cancer. Scale bar: core = 200 µm; inset 60 µm.